Corvus Pharmaceuticals
CRVS
CRVS
164 hedge funds and large institutions have $1.02B invested in Corvus Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 55 increasing their positions, 30 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
83% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 30
32% more funds holding
Funds holding: 124 → 164 (+40)
20.94% more ownership
Funds ownership: 62.51% → 83.45% (+21%)
Holders
164
Holding in Top 10
5
Calls
$21M
Puts
$8.14M
Top Buyers
| 1 | +$46M | |
| 2 | +$39.8M | |
| 3 | +$36M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$32M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$28M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$17.1M | |
| 3 | -$17.1M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$6.03M |
| 5 |
Jane Street
New York
|
-$5.33M |
